Kingdom Monetary Team LLC. lifted its stake in stocks of Johnson & Johnson (NYSE:JNJ – Loose Record) by way of 258.0% all over the 3rd quarter, Holdings Channel studies. The fund owned 9,268 stocks of the corporate’s inventory after buying an extra 6,679 stocks all over the quarter. Johnson & Johnson accommodates 1.4% of Kingdom Monetary Team LLC.’s portfolio, making the inventory its seventeenth greatest keeping. Kingdom Monetary Team LLC.’s holdings in Johnson & Johnson have been price $1,443,000 as of its most up-to-date SEC submitting.

Numerous different huge traders have additionally made adjustments to their positions within the inventory. Hibernia Wealth Companions LLC bought a brand new stake in Johnson & Johnson within the third quarter price about $27,000. Atlantic Non-public Wealth LLC bought a brand new stake in Johnson & Johnson within the 1st quarter price about $32,000. FNY Funding Advisers LLC bought a brand new stake in Johnson & Johnson within the third quarter price about $37,000. VitalStone Monetary LLC bought a brand new stake in Johnson & Johnson within the 2d quarter price about $48,000. In the end, Horizons Wealth Control lifted its stake in stocks of Johnson & Johnson by way of 1,730.0% within the 2d quarter. Horizons Wealth Control now owns 366 stocks of the corporate’s inventory valued at $61,000 after buying an extra 346 stocks within the ultimate quarter. Institutional traders and hedge finances personal 68.40% of the corporate’s inventory.

Johnson & Johnson Buying and selling Up 0.1 %

NYSE:JNJ opened at $156.35 on Thursday. Johnson & Johnson has a 12-month low of $144.95 and a 12-month top of $180.93. The company has a marketplace capitalization of $376.38 billion, a P/E ratio of eleven.61, a P/E/G ratio of three.18 and a beta of 0.57. The corporate has a debt-to-equity ratio of 0.37, a present ratio of one.21 and a handy guide a rough ratio of 0.96. The trade has a 50 day easy transferring moderate of $152.40 and a 200 day easy transferring moderate of $159.62.

Johnson & Johnson (NYSE:JNJ – Get Loose Record) ultimate launched its quarterly profits information on Tuesday, October seventeenth. The corporate reported $2.66 profits according to percentage (EPS) for the quarter, beating analysts’ consensus estimates of $2.52 by way of $0.14. Johnson & Johnson had a go back on fairness of 37.14% and a web margin of 36.32%. The trade had income of $21.35 billion all over the quarter, in comparison to analyst estimates of $21 billion. Equities analysis analysts expect that Johnson & Johnson will put up 9.96 EPS for the present yr.

Johnson & Johnson Dividend Announcement

The trade additionally just lately disclosed a quarterly dividend, which used to be paid on Tuesday, December fifth. Buyers of document on Tuesday, November twenty first got a dividend of $1.19 according to percentage. The ex-dividend date used to be Monday, November twentieth. This represents a $4.76 dividend on an annualized foundation and a yield of three.04%. Johnson & Johnson’s dividend payout ratio is these days 35.34%.

Analysts Set New Value Objectives

A number of analysis corporations have just lately weighed in on JNJ. Cantor Fitzgerald reaffirmed an “obese” ranking on stocks of Johnson & Johnson in a analysis observe on Monday, December 18th. Wells Fargo & Corporate downgraded Johnson & Johnson from an “obese” ranking to an “equivalent weight” ranking and dropped their goal value for the corporate from $170.00 to $163.00 in a file on Wednesday, December thirteenth. Raymond James dropped their goal value on Johnson & Johnson from $179.00 to $172.00 and set an “outperform” ranking at the inventory in a file on Wednesday, October 18th. UBS Team upgraded Johnson & Johnson from a “impartial” ranking to a “purchase” ranking and raised their goal value for the corporate from $167.00 to $180.00 in a file on Friday, December 1st. In the end, HSBC initiated protection on Johnson & Johnson in a file on Wednesday, September sixth. They set a “grasp” ranking and a $175.00 value goal at the inventory. 8 analysts have rated the inventory with a grasp ranking, six have given a purchase ranking and one has given a powerful purchase ranking to the corporate’s inventory. Consistent with MarketBeat, the inventory has a mean ranking of “Average Purchase” and a mean goal value of $168.75.

Get Our Newest Analysis Record on Johnson & Johnson

About Johnson & Johnson

(Loose Record)

Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells more than a few merchandise within the healthcare box international. The corporate’s Shopper Well being phase supplies pores and skin well being/good looks merchandise underneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise underneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise underneath the LISTERINE logo; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and allergic reaction merchandise; BENADRYL and ZYRTEC allergic reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disorder merchandise.

Featured Articles

Need to see what different hedge finances are keeping JNJ? Seek advice from HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Loose Record).

Obtain Information & Scores for Johnson & Johnson Day by day – Input your e mail deal with beneath to obtain a concise day-to-day abstract of the most recent information and analysts’ scores for Johnson & Johnson and similar firms with MarketBeat.com’s FREE day-to-day e mail e-newsletter.